In Vitro and in Vivo Evaluation Of Pharmacological Activites of Pouzolzia Sanguinea

Autor: Mmu Chowdhury, Sms Islam, Md. Qamrul Ahsan, M.T. Alam, MT Nasim

Publikováno v: Journal of Bio-Science. 29:31-42

Pouzolzia sanguinea grows in tropical and sub-tropical regions of Bangladesh, used for a variety of purposes including pain, rheumatoid kidney diseases in traditional medicine. The crude ethanolic leaf extract of P. sanguinea with its different fract

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5b7090195e789a8c5ba71ea1dfc6b6d6
https://doi.org/10.3329/jbs.v29i2.54952

Cutaneous lymphadenoma

Autor: Mmu Chowdhury, H. S. Inaloz, Arthur G. Knight

Publikováno v: Journal of the European Academy of Dermatology and Venereology. 15:481-483

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ba857d5e1c6e33c5ef4d67572699c3ac
https://doi.org/10.1046/j.1468-3083.2001.00302.x

Dermoid cyst with unusual basaloid differentiation

Autor: S Varma, Pja Holt, H S Inalöz, Mmu Chowdhury

Publikováno v: Journal of the European Academy of Dermatology and Venereology. 15:268-269

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::afef29dd29ddc6529fef466d80deed2b
https://doi.org/10.1046/j.1468-3083.2001.02644.x

Sensitisation to the acrylate co-polymers glyceryl acrylate/acrylic acid co-polymer, sodium polyacrylate and acrylates/C10-30 alkyl acrylate cross-polymer (Carbopol®) is rare.

Autor: Soriano LF; University Hospital Southampton NHS Trust, Southampton, UK., Chowdhury MMU; University Hospital of Wales, Cardiff, UK., Cousen P; South Tees Hospital NHS Foundation Trust, Middlesbrough, UK., Dawe S; West Herts NHS Trust, Harpenden, UK., Ghaffar SA; Ninewells Hospital and Medical School, Dundee, UK., Haworth A; St Mary's Hospital, Portsmouth, UK., Holden CR; Sheffield Teaching Hospitals Foundation Trust, Sheffield, UK., Hollywood A; South Infirmary Victoria University Hospital, Cork, Ireland., Johnston GA; University Hospitals of Leicester NHS Trust, Leicester, UK., Kirk S; SK-CRS Ltd, Nottingham, UK., Mughal AA; Swansea Bay University Health Board, Swansea, UK., Orton DI; OneWelbeck Skin Health and Allergy, London, UK., Parker R; THG Labs (Acheson), Wiltshire, UK., Rajeev A; East Kent Hospitals University NHS Foundation Trust, Kent, UK., Scharrer K; United Lincolnshire Hospitals Trust, Lincolnshire, UK., Sinha A; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK., Stone NM; Aneurin Bevan University Healthboard, Newport, UK., Thompson D; Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK., Wakelin S; OneWelbeck Skin Health and Allergy, London, UK.; Imperial College Healthcare NHS Trust, London, UK., Whitehouse H; Leeds teaching Hospitals NHS Trust, Leeds, UK., Wootton C; Oxford University Hospitals NHS Trust, Oxford, UK., Buckley DA; Sulis Hospital, Bath, UK.

Publikováno v: Contact dermatitis [Contact Dermatitis] 2024 Dec; Vol. 91 (6), pp. 491-496. Date of Electronic Publication: 2024 Aug 26.

Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.

Autor: Tatovic D; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., McAteer MA; Midatech Pharma PLC, Cardiff, UK., Barry J; Midatech Pharma PLC, Cardiff, UK., Barrientos A; Midatech Pharma PLC, Cardiff, UK., Rodríguez Terradillos K; Midatech Pharma PLC, Cardiff, UK., Perera I; Midatech Pharma PLC, Cardiff, UK., Kochba E; NanoPass Technologies Ltd., Nes Ziona, Israel., Levin Y; NanoPass Technologies Ltd., Nes Ziona, Israel., Dul M; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Coulman SA; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., Birchall JC; School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK., von Ruhland C; Central Biotechnology Services, Cardiff University, Cardiff, UK., Howell A; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Stenson R; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Alhadj Ali M; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Luzio SD; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Dunseath G; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Cheung WY; Diabetes Research Unit Cymru, Institute for Life Sciences, Swansea University, Swansea, UK., Holland G; Swansea Trials Unit, Swansea University Medical School, Swansea, UK., May K; Department of Cellular Pathology, University Hospital of Wales, Cardiff, UK., Ingram JR; Division of Infection & Immunity, Cardiff University School of Medicine, Cardiff, UK., Chowdhury MMU; Welsh Institute of Dermatology, University Hospital of Wales, Cardiff, UK., Wong FS; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Casas R; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences, Linköping University, Linköping, Sweden., Dayan C; Diabetes Research Group, Cardiff University School of Medicine, Cardiff, UK., Ludvigsson J; Division of Pediatrics, Department of Biomedical and Clinical Sciences, Faculty of Medicine and Health Sciences and Crown Princess Victoria Children´s Hospital, Linköping University, Linköping, Sweden.

Publikováno v: Immunotherapy advances [Immunother Adv] 2022 Jan 27; Vol. 2 (1), pp. ltac002. Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2022).